The estimated Net Worth of Guojuan Liao is at least $3.25 millió dollars as of 18 November 2020. Guojuan Liao owns over 1,354 units of Brooks Automation stock worth over $1,450,734 and over the last 6 years he sold BRKS stock worth over $136,016. In addition, he makes $1,658,870 as President - GENEWIZ at Brooks Automation.
Guojuan has made over 2 trades of the Brooks Automation stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,354 units of BRKS stock worth $94,265 on 18 November 2020.
The largest trade he's ever made was selling 1,354 units of Brooks Automation stock on 18 November 2020 worth over $94,265. On average, Guojuan trades about 464 units every 74 days since 2018. As of 18 November 2020 he still owns at least 12,827 units of Brooks Automation stock.
You can see the complete history of Guojuan Liao stock trades at the bottom of the page.
Dr. Guojuan Liao serves as President - GENEWIZ of the Company. She was appointed President, GENEWIZ in November 2018 upon the completion of Brooks’ acquisition of GENEWIZ. In 1999. Dr. Liao co-founded the GENEWIZ Group (“GENEWIZ”), a global provider of genomics services, including Sanger sequencing, next generation sequencing, gene synthesis, molecular biology, and GLP/CLIA regulatory services and held various leadership positions, most recently as Chief Executive Officer since January 1, 2017.
As the President - GENEWIZ of Brooks Automation, the total compensation of Guojuan Liao at Brooks Automation is $1,658,870. There are 2 executives at Brooks Automation getting paid more, with Stephen Schwartz having the highest compensation of $3,971,410.
Guojuan Liao is 54, he's been the President - GENEWIZ of Brooks Automation since 2018. There are 16 older and 7 younger executives at Brooks Automation. The oldest executive at Brooks Automation, Inc. is A. Clinton Allen, 76, who is the Independent Director.
Guojuan's mailing address filed with the SEC is 111 Corporate Blvd, South Plainfield, NJ 07080, USA.
Over the last 21 years, insiders at Brooks Automation have traded over $110,337,278 worth of Brooks Automation stock and bought 84,885 units worth $755,883 . The most active insiders traders include Stephen S Schwartz, Amin J Khoury és A Clinton Allen. On average, Brooks Automation executives and independent directors trade stock every 22 days with the average trade being worth of $1,392,261. The most recent stock trade was executed by David Jarzynka on 19 November 2021, trading 10,216 units of BRKS stock currently worth $1,228,883.
Brooks Automation Inc. is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europeand Asia.
Brooks Automation executives and other stock owners filed with the SEC include: